Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
SUMINISTRO DE ECULIZUMAB (SOLIRIS®)
Reference number: GPNSU2200005
II.1.2)Main CPV code
33690000 Various medicinal products
II.1.3)Type of contract
Supplies
II.2)Description
II.2.1)Title:
Lot No: UNICO
II.2.3)Place of performance
NUTS code: ES300 Madrid
Main site or place of performance:
Hospital Universitario Infanta Sofia
II.2.4)Description of the procurement at the time of conclusion of the
contract:
SUMINISTRO DE ECULIZUMAB (SOLIRIS®)
II.2.7)Duration of the contract, framework agreement, dynamic purchasing system or
concession
Duration in months: 12
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
Section V: Award of contract/concession
V.2)Award of contract/concession
V.2.1)Date of conclusion of the contract/concession award decision:
12/11/2022
V.2.2)Information about tenders
The contract/concession has been awarded to a group of economic operators: no
V.2.3)Name and address of the contractor/concessionaire
Official name: ALEXION PHARMA SPAIN, S.L.
National registration number: B64494784
Town: BARCELONA
NUTS code: ES511 Barcelona
Country: Spain
The contractor/concessionaire is an SME: yes
V.2.4)Information on value of the contract/lot/concession (at the time of conclusion
of the contract;excluding VAT)
Total value of the procurement: 648 840.00 EUR
Section VI: Complementary information
VI.3)Additional information:
VI.4)Procedures for review
VI.4.1)Review body
Official name: Tribunal Administrativo de Contratación Pública de la Comunidad de Madrid
Postal address: Carrera de San Jerónimo, 13 - 1ª planta
Town: Madrid
Postal code: 28014
Country: Spain
E-mail:
tribunal.contratacion@madrid.org
Telephone: +34 917206346 /45
Fax: +34 917206347
VI.4.3)Review procedure
Precise information on deadline(s) for review procedures:
El plazo de interposición es de 15 días hábiles contados a partir del siguiente a aquél en el que se notifique o publique el acto impugnado y con las particularidades previstas
en el artículo 50 de la Ley 9/2017 de 8 de noviembre, de contratos del Sector Público.
VI.4.4)Service from which information about the review procedure may be
obtained
Official name: Tribunal Administritativo de Contratación Pública de la Comunidad de Madrid
Postal address: Carrera de San Jerónimo, 13 - 1ª planta
Town: Madrid
Postal code: 28014
Country: Spain
E-mail:
tribunal.contratacion@madrid.org
Telephone: +34 917206346 /45
Fax: +34 917206347
VI.5)Date of dispatch of this notice:
30/10/2023
Section VII: Modifications to the contract/concession
VII.1)Description of the procurement after the modifications
VII.1.1)Main CPV code
33690000 Various medicinal products
VII.1.2)Additional CPV code(s)
VII.1.3)Place of performance
NUTS code: ES300 Madrid
Main site or place of performance:
Hospital Universitario Infanta Sofia
VII.1.4)Description of the procurement:
1 PRORROGA 12 MESES CONTRATO DE SUMINISTRO DE Eculizumab (Soliris®)
VII.1.5)Duration of the contract, framework agreement, dynamic purchasing system or
concession
Duration in months: 12
VII.1.6)Information on value of the contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession: 648 840.00 EUR
VII.1.7)Name and address of the contractor/concessionaire
Official name: ALEXION PHARMA SPAIN, S.L.
National registration number: B64494784
Town: BARCELONA
NUTS code: ES511 Barcelona
Country: Spain
The contractor/concessionaire is an SME: yes
VII.2)Information about modifications
VII.2.1)Description of the modifications
Nature and extent of the modifications (with indication of possible earlier changes to the contract):
1 PRORROGA 12 MESES DEL 14.11.2023 AL 13.11.2024
VII.2.2)Reasons for modification
Need for additional works, services or supplies by the original contractor/concessionaire (Art. 43(1)(b) of Directive 2014/23/EU, Art. 72(1)(b) of Directive 2014/24/EU, Art. 89(1)(b)
of Directive 2014/25/EU)
Description of the economic or technical reasons and the inconvenience or duplication of cost preventing a change of contractor:
1 PRORROGA 12 MESES CONTRATO DE SUMINISTRO DE Eculizumab (Soliris®)
VII.2.3)Increase in price
Updated total contract value before the modifications (taking into account possible earlier contract modifications and price adaptions and, in the case of Directive 2014/23/EU,
average inflation in the Member State concerned)
Value excluding VAT: 648 840.00 EUR
Total contract value after the modifications
Value excluding VAT: 1 297 680.00 EUR